Status:
UNKNOWN
Seroprevalence of Pertussis Among Healthy Children and Adolescents in Kazakhstan
Lead Sponsor:
Scientific and practical center of sanitary and epidemiological expertise and monitoring
Conditions:
Pertussis
Eligibility:
All Genders
10-18 years
Brief Summary
Seroprevalence of pertussis among older children and adolescents in Kazakhstan: A cross sectional study. Justification: to describe the distribution of anti-pertussis toxin (PT) antibodies (IgA and I...
Detailed Description
Pertussis due to infection with Bordetella pertussis (B pertussis) is a well-known cause of persistent cough primarily affecting infants and young children. Repeated administration of the vaccine is o...
Eligibility Criteria
Inclusion
- 10-18 years old
- Informed consent obtained from parents or guardian(s) and assent from patient.
- Enrollment following a visit at the study center.
- Documented vaccination history
Exclusion
- Inclusion criteria:
- 10-18 years old
- Informed consent obtained from parents or guardian(s) and assent from patient.
- Enrollment following a visit at the study center.
- Documented vaccination history
- Exclusion criteria:
- ≤10 years and ≥ 19 years
- Pertussis immunization during the last 12 months
- No informed consent obtained from one parent or guardian.
- Immunocompromised patients
- Patients with acute infectious diseases
Key Trial Info
Start Date :
January 25 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 5 2022
Estimated Enrollment :
520 Patients enrolled
Trial Details
Trial ID
NCT04779853
Start Date
January 25 2021
End Date
July 5 2022
Last Update
March 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Scientific and Practical Center of Sanitary and Epidemiological Expertise and Monitoring
Almaty, Kazakhstan, 050008